The prognostic value of phosphorylated Akt in breast cancer: a systematic review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of phosphorylated Akt in breast cancer: a systematic review
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-01-13
DOI
10.1038/srep07758
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential role of Akt phosphorylation in human cancers
- (2017) J. Cicenas INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: A meta-analysis
- (2014) Yang Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
- (2013) Chee Khoon Lee et al. JNCI-Journal of the National Cancer Institute
- PKB/Akt-Dependent Regulation of Cell Motility
- (2013) G. Xue et al. JNCI-Journal of the National Cancer Institute
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
- (2012) T. Sangai et al. CLINICAL CANCER RESEARCH
- Biomarkers for the clinical management of breast cancer: International perspective
- (2012) Neill Patani et al. INTERNATIONAL JOURNAL OF CANCER
- Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis
- (2012) Nirav Thosani et al. JOURNAL OF CLINICAL ONCOLOGY
- Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression
- (2012) Melanie Spears et al. JOURNAL OF PATHOLOGY
- Depression and Risk of Stroke Morbidity and Mortality
- (2011) An Pan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phosphorylated Akt and Phosphorylated mTOR Expression in Breast Invasive Carcinomas: Analysis of 530 Cases
- (2011) Jungsuk An et al. Journal of Breast Cancer
- Recombinant VP1, an Akt Inhibitor, Suppresses Progression of Hepatocellular Carcinoma by Inducing Apoptosis and Modulation of CCL2 Production
- (2011) Tai-An Chen et al. PLoS One
- Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation
- (2010) Chunjie Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma
- (2010) Hermien Hartog et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Akt inhibitors in clinical development for the treatment of cancer
- (2010) Sumanta Kumar Pal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer
- (2010) Nagai INTERNATIONAL JOURNAL OF ONCOLOGY
- Clinical significance of pAKT and CD44v6 overexpression with breast cancer
- (2010) Pei Yu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Clinical Significance of PTEN and p-Akt Co-Expression in HER2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab-Based Therapies
- (2010) A. Fabi et al. ONCOLOGY
- EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
- (2009) S. Gori et al. ANNALS OF ONCOLOGY
- Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer
- (2009) Yousif O. Al-Bazz et al. EUROPEAN JOURNAL OF CANCER
- Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma
- (2009) Alessandra Capodanno et al. HUMAN PATHOLOGY
- Low phosphorylation of estrogen receptor (ER ) serine 118 and high phosphorylation of ER serine 167 improve survival in ER-positive breast cancer
- (2008) H. Yamashita et al. ENDOCRINE-RELATED CANCER
- Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy
- (2008) Kan Yonemori et al. MEDICAL ONCOLOGY
- Activated Akt as an indicator of prognosis in gastric cancer
- (2008) Caterina Cinti et al. VIRCHOWS ARCHIV
- Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer
- (2007) F. Andre et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now